← Back to Search

Corticosteroid

40 units for Sarcoidosis (ACPS Trial)

Phase 4
Waitlist Available
Led By Robert P Baughman, MD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

ACPS Trial Summary

An randomized trial of two maintenance doses of Acthar Gel for patients with chronic pulmonary sarcoidosis. Patients will be observed for 24 weeks of treatment.

Eligible Conditions
  • Sarcoidosis

ACPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Steroid toxicity
Secondary outcome measures
Chest x-ray
Forced Vital Capacity (FVC)
PET scan
+1 more

ACPS Trial Design

2Treatment groups
Active Control
Group I: 40 unitsActive Control1 Intervention
40 units of ACTHAR gel will be given twice a week for 22 weeks after loading
Group II: 80 unitsActive Control1 Intervention
80 units ACTHAR gel will be given twice a week for 22 weeks after initial loading

Find a Location

Who is running the clinical trial?

MallinckrodtIndustry Sponsor
201 Previous Clinical Trials
16,208 Total Patients Enrolled
6 Trials studying Sarcoidosis
99 Patients Enrolled for Sarcoidosis
University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,366 Total Patients Enrolled
14 Trials studying Sarcoidosis
3,752 Patients Enrolled for Sarcoidosis
Robert P Baughman, MDPrincipal InvestigatorUniversity of Cincinnati
10 Previous Clinical Trials
2,570 Total Patients Enrolled
9 Trials studying Sarcoidosis
2,555 Patients Enrolled for Sarcoidosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Robert P Baughman 2014. "Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02188017.
All > Acth > Sarcoidosis
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top